CNTA

NASDAQStock

Centessa Pharmaceuticals plc

$27.59-0.63 (-2.23%)

52-Week Range

$10.71

$29.91

Key Stats

Market Cap

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.55

Volume

658.7K

Avg Volume

1.2M

Performance

+15.53%

+4.09%

+23.61%

YTD

+14.90%

+61.35%

+589.11%

+25.15%

Price Chart

ETF Exposure

CNTA is held by 13 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IBRN	iShares Neuroscience and Healthcare ETF	3.52%	6,323	$174K	$4.9M	0.47%
FMED	FIDELITY DISRUPTIVE MEDICINE ETF	0.91%	22,800	$629K	$60.9M	0.50%
BBC	Virtus Biotech Clinical Trials ETF	0.77%	10,892	$301K	$39.0M	0.65%
FPXE	First Trust IPOX Europe Equity Opportunities ETF	0.57%	991	$27K	$4.8M	0.70%
CGMM	Capital Group U.S. Small and Mid Cap ETF	0.50%	309,751	$8.5M	$1.66B	0.51%
ACSG	American Century Small Cap Growth Insights ETF	0.36%	1,284	$35K	$9.7M	0.49%
TNXT	T. Rowe Price Innovation Leaders ETF	0.22%	1,253	$35K	$15.9M	0.49%
IBBQ	Invesco Nasdaq Biotechnology ETF	0.20%	5,405	$149K	$74.5M	0.19%
IBB	iShares Biotechnology ETF	0.17%	523,542	$14.4M	$8.50B	0.44%
TMSL	T. Rowe Price Small-Mid Cap ETF	0.14%	79,008	$2.2M	$1.57B	0.55%
BIB	ProShares - Ultra Nasdaq Biotechnology	0.14%	4,331	$119K	$86.8M	1.19%
ISCF	iShares International Small-Cap Equity Factor ETF	0.01%	2,641	$73K	$596.7M	0.24%
ONEQ	FIDELITY NASDAQ COMPOSITE INDEX ETF	0.01%	27,138	$749K	$9.01B	0.21%

About CNTA ETF Exposure

Centessa Pharmaceuticals plc (CNTA) is held by 13 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $27.59. Investors can gain exposure to CNTA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CNTA, sorted by portfolio weight.